Sunshine Biopharma (SBFM) Short Interest Ratio & Short Volume $1.29 +0.04 (+3.20%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$1.25 -0.04 (-3.18%) As of 04/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sunshine Biopharma Short Interest DataSunshine Biopharma (SBFM) has a short interest of 141,300 shares, representing 3.89% of the float (the number of shares available for trading by the public). This marks a 24.93% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 615,283 shares to cover all short positions.Current Short Interest141,300 sharesPrevious Short Interest113,100 sharesChange Vs. Previous Month+24.93%Dollar Volume Sold Short$269,883.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares2,707,000 sharesFloat Size3,630,000 sharesShort Percent of Float3.89%Today's Trading Volume11,669,986 sharesAverage Trading Volume615,283 sharesToday's Volume Vs. Average1,897% Short Selling Sunshine Biopharma? Sign up to receive the latest short interest report for Sunshine Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSBFM Short Interest Over TimeSBFM Days to Cover Over TimeSBFM Percentage of Float Shorted Over Time Sunshine Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025141,300 shares $269,883.00 +24.9%3.9%0.1 $1.91 3/15/2025113,100 shares $218,283.00 +78.1%4.2%1.4 $1.93 2/28/202563,500 shares $145,415.00 +10.4%2.3%0.4 $2.29 2/15/202557,500 shares $144,325.00 -31.1%2.1%0.1 $2.51 1/31/202583,500 shares $237,975.00 +6.8%3.1%0.1 $2.85 1/15/202578,200 shares $226,780.00 -64.1%2.9%0.1 $2.90 12/31/2024217,900 shares $653,700.00 -54.1%8.0%0.3 $3.00 12/15/2024474,300 shares $1.30 million -14.6%23.7%0.7 $2.75 11/30/2024555,600 shares $1.59 million +137.3%27.8%0.8 $2.86 11/15/2024234,100 shares $550,135.00 -37.4%11.7%0.4 $2.35 Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024374,100 shares $1.05 million +16.4%18.7%2.1 $2.82 10/15/2024321,500 shares $948,425.00 -13.3%16.1%1.9 $2.95 9/30/2024370,900 shares $1.18 million +66.9%30.4%2.3 $3.18 9/15/2024222,300 shares $622,440.00 -9.4%18.2%1.4 $2.80 8/31/2024245,300 shares $696,652.00 +13.5%20.1%1.9 $2.84 8/15/2024216,200 shares $698,326.00 +816.1%17.7%1.6 $3.23 7/31/202423,600 shares $6,350.76 -93.5%2.0%0.2 $0.27 7/15/2024360,900 shares $121,984.20 -57.7%1.5%0.1 $0.34 6/30/2024852,200 shares $355,793.50 -45.7%3.7%0.2 $0.42 6/15/20241,570,000 shares $518,100.00 +894.9%8.3%0.4 $0.33 5/31/2024157,800 shares $98,861.70 -10.5%0.9%0 $0.63 5/15/2024176,300 shares $157,330.12 -38.0%1.0%0.1 $0.89 4/30/2024284,500 shares $248,937.50 +307.6%29.8%0.1 $0.88 4/15/202469,800 shares $426,478.00 -90.1%7.3%0.1 $6.11 3/31/2024706,700 shares $42,755.35 -27.2%0.8%0 $0.06 3/15/2024971,000 shares $58,260.00 +118.1%1.1%0.1 $0.06 2/29/2024445,300 shares $24,669.62 -26.1%1.0%0 $0.06 2/15/2024602,600 shares $38,265.10 +487.3%1.3%0.3 $0.06 1/31/2024102,600 shares $26,265.60 -9.1%0.4%0.5 $0.26 1/15/2024112,900 shares $28,642.73 -1.6%0.5%0.7 $0.25 12/31/2023114,700 shares $31,141.05 +90.5%0.5%0.7 $0.27 12/15/202360,200 shares $14,327.60 -18.9%0.3%0.4 $0.24 11/30/202374,200 shares $21,443.80 -22.4%0.3%0.5 $0.29 11/15/202395,600 shares $26,194.40 -29.2%0.4%0.7 $0.27 10/31/2023135,100 shares $40,421.92 -35.0%0.6%0.9 $0.30 10/15/2023207,700 shares $66,443.23 +8.6%1.0%1.3 $0.32 9/30/2023191,200 shares $61,184.00 +3.4%0.9%1.1 $0.32 9/15/2023184,900 shares $73,368.32 -34.3%0.9%1.1 $0.40 8/31/2023281,200 shares $120,606.68 -52.5%1.3%1.5 $0.43 8/15/2023591,900 shares $307,788.00 +701.0%2.8%2.7 $0.52Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment… 7/31/202373,900 shares $37,689.00 -52.7%0.4%0.1 $0.51 7/15/2023156,300 shares $75,070.89 -32.2%0.9%0.1 $0.48 6/30/2023230,500 shares $113,982.25 -28.9%1.3%0.2 $0.49 6/15/2023324,000 shares $179,755.20 -39.9%1.8%0.2 $0.55 5/31/2023538,800 shares $328,668.00 -67.5%3.0%0.4 $0.61 5/15/20231,660,000 shares $1.05 million +525.9%9.2%1.3 $0.63 4/30/2023265,200 shares $165,935.64 -6.1%1.5%2.1 $0.63 4/15/2023282,500 shares $192,100.00 +28.1%1.5%1.9 $0.68 3/31/2023220,600 shares $161,214.48 -27.7%1.2%1.1 $0.73 3/15/2023305,300 shares $242,835.62 -13.8%1.7%1.4 $0.80 2/28/2023354,100 shares $319,079.51 -16.9%1.9%1.6 $0.90 2/15/2023426,000 shares $415,137.00 +7.6%2.3%1.9 $0.97 1/31/2023395,800 shares $486,834.00 +28.6%2.1%1.1 $1.23 1/15/2023307,900 shares $253,309.33 -19.4%1.7%0.8 $0.82 12/30/2022381,900 shares $244,416.00 -15.2%2.1%0.7 $0.64 12/15/2022450,400 shares $307,262.88 -5.8%2.5%0.9 $0.68 11/30/2022478,300 shares $378,383.13 +14.0%2.9%0.8 $0.79 11/15/2022419,600 shares $351,163.24 -21.9%2.5%0.7 $0.84 10/31/2022537,200 shares $459,467.16 +1,239.7%3.2%1.1 $0.86 10/15/202240,100 shares $32,280.50 -46.5%0.3%0 $0.81 9/30/202275,000 shares $57,937.50 -30.7%0.5%0.1 $0.77 9/15/2022108,200 shares $105,094.66 -72.7%0.7%0.1 $0.97 8/31/2022396,100 shares $435,710.00 -32.9%2.5%0.4 $1.10 8/15/2022590,700 shares $773,817.00 +20.2%3.7%0.4 $1.31 7/31/2022491,600 shares $530,928.00 +641.5%3.1%0.3 $1.08 7/15/202266,300 shares $74,919.00 No Change0.4%0 $1.13 SBFM Short Interest - Frequently Asked Questions What is Sunshine Biopharma's current short interest? Short interest is the volume of Sunshine Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 141,300 shares of SBFM short. 3.89% of Sunshine Biopharma's shares are currently sold short. Learn More on Sunshine Biopharma's current short interest. What is a good short interest percentage for Sunshine Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.89% of Sunshine Biopharma's floating shares are currently sold short. Is Sunshine Biopharma's short interest increasing or decreasing? Sunshine Biopharma saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 141,300 shares, an increase of 24.9% from the previous total of 113,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sunshine Biopharma's float size? Sunshine Biopharma currently has issued a total of 2,707,000 shares. Some of Sunshine Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sunshine Biopharma currently has a public float of 3,630,000 shares. How does Sunshine Biopharma's short interest compare to its competitors? 3.89% of Sunshine Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sunshine Biopharma: Genprex, Inc. (1.18%), Lipella Pharmaceuticals Inc. (1.09%), Aytu BioPharma, Inc. (1.96%), Apollomics, Inc. (0.39%), GT Biopharma, Inc. (3.24%), Conduit Pharmaceuticals Inc. (112.13%), TransCode Therapeutics, Inc. (12.15%), Alzamend Neuro, Inc. (5.67%), Brainstorm Cell Therapeutics Inc. (2.71%), Soligenix, Inc. (1.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Sunshine Biopharma stock? Short selling SBFM is an investing strategy that aims to generate trading profit from Sunshine Biopharma as its price is falling. SBFM shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sunshine Biopharma? A short squeeze for Sunshine Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SBFM, which in turn drives the price of the stock up even further. How often is Sunshine Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBFM, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Genprex Short Interest Data Lipella Pharmaceuticals Short Interest Data Aytu BioPharma Short Interest Data Apollomics Short Interest Data GT Biopharma Short Interest Data Conduit Pharmaceuticals Short Interest Data TransCode Therapeutics Short Interest Data Alzamend Neuro Short Interest Data Brainstorm Cell Therapeutics Short Interest Data Soligenix Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SBFM) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Introducing your AI trading partner. You don't need to stare at charts, stress over setups, or lose sleep. ...Blue Edge Financial | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThey Scared The Nation And Cashed in on ChaosYou weren’t supposed to notice what just happened. While the headlines screamed about tariffs and Trump, Wa...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.